Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Cherry Angiomas in Individuals With Neurofibromatosis Type 1.
Journal: JAMA dermatology
Published: August 19, 2026
An e-health transition intervention for youth with brain-based disabilities: Pilot and feasibility results from a Randomized Controlled Trial.
Journal: Health care transitions
Published: September 27, 2025
Neurodevelopmental Outcomes From the PREVeNT Trial.
Journal: Pediatric neurology
Published: March 10, 2025
Dosing to Effect With Weekly and Monthly Subcutaneous and Daily Sublingual Buprenorphine: Post Hoc Analysis of a Phase 3 Clinical Trial.
Journal: Journal of addiction medicine
Published: December 02, 2024
NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.
Journal: Acta neuropathologica communications
Published: June 06, 2024
Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) Trial.
Journal: Pediatric neurology
Published: March 05, 2024
Bystander-application of a novel nasal swab optimized for drug delivery is safe and non-traumatic for the general population.
Journal: Drug and alcohol dependence
Published: February 05, 2024
A commentary on the healthcare transition policy landscape for youth with disabilities or chronic health conditions, the need for an inclusive and equitable approach, and recommendations for change in Canada.
Journal: Frontiers in rehabilitation sciences
Published: September 30, 2023
Acute Isolated Thrombocytopenia Secondary to Meloxicam Use: A Case Report.
Journal: Cureus
Published: January 13, 2022
Buprenorphine maintenance treatment in patients with opioid use disorder diagnosed with COVID-19.
Journal: Journal of opioid management
Published: January 11, 2021
Last Updated: 09/26/2026